Search

Dermatologic surgeon Erica Lee offers expert advice to people with skin cancer on their nose, eyelid, or another area of their face.

… Tuesday, July 31, 2018 Summary Dermatologic surgeon Erica Lee offers expert advice to people with skin cancer on their nose, eyelid, or another area of their face. “Keep your face always toward the sunshine — and the shadows will fall behind you,” Walt Whitman once wrote. But what the poet didn’t account

By training computers to detect pathological changes in slides of tumor tissue, digital pathology promises to help doctors provide better patient care.

… Thursday, December 10, 2020 Summary A digital platform that relies on machine learning can accurately identify cancerous changes in breast tissue, according to a new study being presented at the 2020 San Antonio Breast Cancer Symposium. Among doctors, pathology is often considered the backbone of medicine

Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute's Molecular Biology Program.

… Tuesday, December 1, 2009 Summary Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute’s Molecular Biology Program. For Simon N. Powell, research and medicine have always been joint pursuits. Dr. Powell

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute suggests a therapeutic strategy to overcome resistance to PRMT5 inhibition in lymphoma; finds safety and clinical benefit using an engineered adenovirus in combination with immunotherapy against PD-1-resistant melanoma; and uncovers a new type of immune cell that plays a key role in establishing a healthy gut microbiome.

… Thursday, October 13, 2022 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — MSK’s experimental research arm — suggests a therapeutic strategy to overcome resistance to PRMT5 inhibition in lymphoma; finds safety and clinical benefit using an engineered

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.

… Thursday, July 17, 2014 Summary A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors. Drug discovery is “a long, complex effort,” says chemical biologist Gabriela Chiosis , a member of the Sloan Kettering Institute’s Molecular Pharmacology

FoundationOne Heme was developed using technology, methods and computational algorithms developed by Foundation Medicine, combined with Memorial Sloan Kettering’s deep and vast expertise in clinical and laboratory research into hematologic malignancies.

… Saturday, December 7, 2013 Foundation Medicine announced today the launch of its second clinical product, FoundationOne™ Heme, a fully informative genomic profile for hematologic cancers (leukemia, lymphoma and myeloma), as well as many sarcomas and pediatric cancers. The test has been developed in collaboration

Memorial Sloan Kettering Cancer Center (MSKCC) opened a new state-of-the-art outpatient cancer treatment facility in Basking Ridge, New Jersey, today. The new 85,000-square-foot facility incorporates the latest concepts in therapeutic design and offers the most advanced cancer care services.

… Tuesday, September 5, 2006 Memorial Sloan Kettering Cancer Center (MSKCC) opened a new state-of-the-art outpatient cancer treatment facility in Basking Ridge, New Jersey , today. The new 85,000-square-foot facility incorporates the latest concepts in therapeutic design and offers the most advanced cancer

Learn how the Lisa and Scott Stuart Center for Adolescent and Young Adult Cancers at Memorial Sloan Kettering is transforming the experience, care, and outcomes of teens and young adults with cancer.

… Monday, September 27, 2021 Imagine: Just as you’re finding your footing in the real world — graduating school, starting a new job, getting married, building a family — you’re diagnosed with cancer. It sounds implausible, but it happens to 90,000 teens and young adults in America each year. “Nobody is

Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC's new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary setting designed to foster rapid innovations in cancer care.

… Wednesday, July 7, 2010 Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC’s new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary

MSK ranked #17 out of 500 companies and is the second highest ranked hospital.

… Thursday, April 29, 2021 Forbes has named Memorial Sloan Kettering Cancer Center one of America’s Best Employers for Diversity , ranking the organization #17 out of 500 companies, and the second highest ranked hospital. It’s MSK’s second year on the fourth annual list. “At MSK, we’re committed to ensuring